We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Live attenuated chimeric yellow fever dengue virus (serotypes 1 and 2 and 3 and 4)
Australian Public Assessment Report
Device/Product Name
Dengvaxia
Active ingredients
Live attenuated chimeric yellow fever dengue virus (serotypes 1 and 2 and 3 and 4)
AusPAR Date
Published
Sponsor
Submission Number
PM-2016-01679-1-2 / PM-2017-04923-1-2 / PM-2017-04924-1-2
Submission Type
New biological entity (vaccine)
Decision
Approved